Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $26.2 million.

  • Lucid Diagnostics' Total Current Liabilities rose 8391.47% to $26.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year increase of 8391.47%. This contributed to the annual value of $23.5 million for FY2024, which is 1993.74% down from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' Total Current Liabilities is $26.2 million, which was up 8391.47% from $29.4 million recorded in Q2 2025.
  • Lucid Diagnostics' Total Current Liabilities' 5-year high stood at $36.6 million during Q1 2025, with a 5-year trough of $7.9 million in Q2 2022.
  • Over the past 4 years, Lucid Diagnostics' median Total Current Liabilities value was $23.4 million (recorded in 2023), while the average stood at $21.0 million.
  • As far as peak fluctuations go, Lucid Diagnostics' Total Current Liabilities surged by 24874.78% in 2023, and later crashed by 5285.53% in 2024.
  • Over the past 4 years, Lucid Diagnostics' Total Current Liabilities (Quarter) stood at $8.4 million in 2022, then surged by 248.75% to $29.4 million in 2023, then dropped by 19.94% to $23.5 million in 2024, then increased by 11.4% to $26.2 million in 2025.
  • Its Total Current Liabilities stands at $26.2 million for Q3 2025, versus $29.4 million for Q2 2025 and $36.6 million for Q1 2025.